Join John Wylie, Portfolio Manager and Head of Healthcare, as he reviews how Novartis is positioned, provides an overview of the US political risks to the healthcare sector, and addresses how innovation in the prevention of cancer may translate to potential investment profits.
The Magellan Global Fund offers investors the opportunity to invest in a specialised and focused global equity fund. The Fund aims to achieve attractive risk-adjusted returns over the medium to long term while minimising the risk of permanent capital loss. There is also a listed version available under the ASX ticker code MGF.
